Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bio-Rad Laboratories Inc Signs Definitive Agreement to Acquire AbD Serotec from MorphoSys AG


Sunday, 16 Dec 2012 01:41pm EST 

Bio-Rad Laboratories Inc announced that it has signed a definitive agreement to acquire AbD Serotec, a division of MorphoSys AG for EUR53 million in cash. The transaction is subject to certain closing conditions and is expected to be completed in January. 

Company Quote

120.6
0.74 +0.62%
17 Apr 2014